This brand name is authorized in Nigeria.
The drug ALBEGYL contains one active pharmaceutical ingredient (API):
1
|
UNII
140QMO216E - METRONIDAZOLE
|
Metronidazole is an anti-infectious drug belonging to the pharmacotherapeutic group of nitroimidazole derivatives, which have effect mainly on strict anaerobes. This effect is probably caused by interaction with DNS and different metabolites. |
|
This drug has been approved in Nigeria as follows:
Identifier | Form | Presentation | Description | Approval |
---|---|---|---|---|
A4-9812 | Suspension | ALBEGYL SUSPENSION SUSP 200 mg/5 mL 60ML | 17 RNW-PP-228161 ALBEGYL SUSPENSION METRONIDAZOLE 200MG/5ML Metronidazole Benzoate 320mg/5ml(Equivalent to Metronidazole 200mg/5ml); Sucrose; Xanthan gum; Sodium Propyl Paraben; Sodium Methyl Paraben; Citric Acid; Polysorbate(Tween) 80; Glycerin; Tartrazine Yellow; Banana Flavour. A4-9812 Drugs ANTIINFECTIVES FOR SYSTEMIC USE Nigerian Products 60ml POM 1 8/28/2021 ALBEN HEALTH CARE INDUSTRIES LTD., ONITSHA AWKA ROAD, OGIDI ANAMBRA 8033332325 albenng@rocketmail.com Alben Healthcare Industries Limited, KM 15 Old Onitsha Awka Road ,Ogidi, Anambra State, Nigeria., Nigeria | 28/03/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC Group | Classification | |
---|---|---|
P01AB01 | Metronidazole | P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01A Agents against amoebiasis and other protozoal diseases → P01AB Nitroimidazole derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
NG | Registered Drug Product Database | A4-7707, A4-9812 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.